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2H NMR-B) is critical to minimizing surface tension in the alveoli. The C-terminus of SP-B,
residues 59–80, has much of the surface activity of the full protein and serves as a template for the
development of synthetic surfactant replacements. The molecular mechanisms responsible for its ability to
restore lung compliance were investigated with circular dichroism, differential scanning calorimetry,
and 31P and 2H solid-state NMR spectroscopy. SP-B59–80 forms an amphipathic helix which alters lipid
organization and acyl chain dynamics in ﬂuid lamellar phase 4:1 DPPC:POPG and 3:1 POPC:POPG MLVs. At
higher levels of SP-B59–80 in the POPC:POPG lipid system a transition to a nonlamellar phase is observed
while DPPC:POPG mixtures remain in a lamellar phase. Deuterium NMR shows an increase in acyl chain
order in DPPC:POPG MLVs on addition of SP-B59–80; in POPC:POPG MLVs, acyl chain order parameters
decrease. Our results indicate SP-B59–80 penetrates deeply into DPPC:POPG bilayers and binds more
peripherally to POPC:POPG bilayers. Similar behavior has been observed for KL4, a peptide mimetic of SP-B
which was originally designed using SP-B59–80 as a template and has been clinically demonstrated to be
successful in treating respiratory distress syndrome. The ability of these helical peptides to differentially
partition into lipid lamellae based on their degree of monounsaturation and subsequent changes in lipid
dynamics suggest a mechanism for lipid organization and trafﬁcking within the dynamic lung environment.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionA fundamental problem associated with breathing stems from the
high surface area of the lung: the need to minimize surface tension in
small, gas-containing, aqueous lined structures. The task of reducing
surface tension and increasing lung compliance is accomplished by
lung surfactant. Lung surfactant protein B (SP-B), which directly
interacts with the phospholipids in surfactant, is particularly critical to
its function [1]. Mature SP-B is a homodimer, made up of two 79-81
amino acidmonomers, that is extremely hydrophobic, containing high
levels of valine, leucine, isoleucine, alanine, phenylalanine, and
tryptophan [2–4]. SP-B has a net cationic charge greater than +5 at
physiologic pH. The native form of the protein contains 6 cysteineslear magnetic resonance; CSA,
, differential scanning calori-
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ll rights reserved.that form intramolecular disulﬁde bonds and a seventh cysteine
residue that forms an intermolecular disulﬁde bond. The conservation
of the 6 cysteines that form intramolecular disulﬁde bridges, the
pattern of disulﬁde formation, and its hydrophobicity place SP-B in the
saposin family of proteins. Other proteins in the saposin family include
amoebapores from Entamoeba histolytica, acid sphingomyelinase,
acyloxyacyl hydrolase, and sphingolipid activator proteins A–D
(saposins A–D) [5]. The higher hydrophobicity of SP-B and cysteine
48 which forms the disulﬁde bridge connecting monomers make SP-B
unique among the members of the saposin family. The hydrophobicity
and disulﬁde bridges in SP-B also make puriﬁcation or heterologous
expression of the protein in large quantities impractical. Synthetic,
peptide-based lung surfactant replacements for treatment of RDS
have received notable attention as they remove the immunologic risks
associated with animal-derived surfactants [6–8].
While the entire 80 amino acid SP-B protein is essential for lung
surfactant organization, dynamics and respiration, fragments of the
native sequence have shown signiﬁcant biophysical function, particu-
larly peptides corresponding to the N-terminal and C-terminal 20–25
amino acids [3,9]. To date, the N-terminal region of the peptide,
speciﬁcally residues 1–25, has beenmore extensively studied in termsof
its molecular properties and possible structural adaptation in different
lipid environments. While both N- and C-terminal peptides have
Fig. 1. CD spectra at 45 °C of SP-B'59–80 at a P:L molar ratio of 1:100 in 4:1 DPPC:POPG
(——) and 3:1 POPC:POPG (- - - - - -). The ﬁnal peptide concentration was 40 μM.
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been achieved with a chimeric construct of the two [10]. Both peptides
form cationic amphipathic helices in SDSmicelles and SP-B1–25 has been
determined to be helical in lipid environments [11–14] , but their
individual roles in lipid trafﬁcking are not well understood. The
preponderance of leucines and relative lack of prolines and aromatic
sidechains in the C-terminus distinguish it from the N-terminus, which
contains four prolines as well as a phenylalanine and a tryptophan. The
peptides also have varying spacing between hydrophilic and hydro-
phobic amino acids. These differences could lead to varying secondary
structures and penetration into lipid lamellae as well as different effects
on phospholipid dynamics.
The C-terminal fragment of SP-B, speciﬁcally residues 59–80, (SP-
B59–80) has shown efﬁcacy in altering phospholipid properties based
on in vitro assays measuring surface tension, such as pulsating bubble
surfactometry, as well as in vivo assays demonstrating gain of function
in surfactant-deﬁcient fetal rabbits [3]. As with the N-terminus, the C-
terminal peptide is believed to form an amphipathic helix involved in
lipid organization, but direct structural measurements in varying lipid
contexts have to date not been documented. A recent solution NMR
study of the C-terminus of SP-B (residues 63–78) reconstituted in
either SDS micelles or the organic solvent HFIP found the ﬁrst ﬁve
residues to be unstructured and established that the rest of the
sequence formed a helix in both SDSmicelles and organic solvent [13].
A previous CD study [12] of SP-B59–80 in TFE and SDS micelles and the
solution NMR study are the only documented structural assessments
of the C-terminal region of SP-B. While these measurements predict
the last 21 amino acids of SP-B to be helical, it should be noted that its
exact structural adaptation in a lipid environment, where its function
in lipid adsorption and resorption is most important, may vary. Also, a
canonicalα-helical conformation (3.6 residues/turn) leads to unfavor-
able placement of the charged residues in a lipid milieu. Despite the
scarcity of literature pertaining to residues 59–80 of SP-B, it is widely
believed that many in vivo activities of SP-B are fulﬁlled by the C-
terminal end based on both in vitro and in vivo studies [3,10].
Of particular clinical interest, the last 22 aminoacids of SP-B served as
the template for designing the KL4 peptide, KLLLLKLLLLKLLLLKLLLLK [8].
The basis of the sequence for KL4 was the charge distribution and
hydrophilic/hydrophobic ratio of the primary sequence of SP-B59–80. To
date, KL4 has enjoyed the most clinical success as a potential synthetic
replacement for SP-B [15–19]. While KL4 was developed based on the
hydrophilic/hydrophobic pattern in SP-B59–80, their primary sequences
have only modest similarity with SP-B59–80 containing negatively
charged terminal amino acids and variable spacing of three-four
hydrophobic residues between polar or charged residues. A signiﬁcant
question remaining is whether KL4 and SP-B59–80 act similarly, despite
clear deviations at the primary amino acid level. Based on its charge
distribution andCD and FTIR studies of intact SP-B in lipid environments,
SP-B is thought be comprised of amphipathic helices at lipid interfaces
[20,21]. However, an FTIR study of KL4 in DPPC/DPPG concluded the
peptide formed a helix spanning the bilayers and it has beenposited that
KL4 might more closely mimic lung surfactant protein C (SP-C) rather
than the C-terminus of SP-B [22]. More recent IR andNMR studies of KL4
conclude that it binds to the lipid interface but its structure and
penetration are lipid and pressure dependent [23–25]. One key to
understanding how similar KL4 is to SP-B59–80 in its behavior is to
examine the binding of SP-B59–80 to model lipid membrane systems, its
effects on their dynamics, and any effects on the Lβ to Lα phase transition
in DPPC lipids; these results can then be directly compared to studies of
KL4. Thus, we chose to study the effects of SP-B59–80 on 4:1 DPPC:POPG
and 3:1 POPC:POPG MLVs. The former composition is similar to
formulations commonly used in studying lung surfactant, while the
latter is a paradigm lipid system commonly employed to probe peptide/
lipid interactions, particularly in studies of cationic, amphipathic helices
[26–28]. Lipid phases of these compositions could also be found in
localized areas of the alveoli during the breathing cycle [29].Based on understanding the properties of SP-B59–80, new non-
natural peptide analogs of SP-B that exploit the protein's qualities in
altering lipid dynamics could be made to extend or enhance artiﬁcial
lung surfactant therapies. Thus, understanding how SP-B59–80 affects
the molecular and biophysical properties of lipids is of particular
relevance to the treatment of various forms of RDS.
2. Materials and methods
2.1. Synthesis of SP-B59–80
SP-B59–80, (DTLLGRMLPQLVCRLVLRCSMD) was synthesized via
solid-phase peptide synthesis on a Wang resin (ABI 430, ICBR, UF)
and cleaved from the resinwith King's reagent and ether precipitated.
The cleaved product was puriﬁed via RP-HPLC using a C18 Vydac
column with a water/acetonitrile gradient (containing 0.3% TFA). The
fractions corresponding to SP-B59–80 were collected and purity of the
product was veriﬁed bymass spectrometrywith amass to charge ratio
of (m/z) of 2533. Driedpeptidewasweighed anddissolved inmethanol
to a stock concentration of approximately 1 mM, and aliquots were
analyzed by amino acid analysis for a more accurate determination of
concentration (Molecular Structure Facility, UC Davis).
2.2. Heterologous expression of a SP-B59–80 double mutant (SP-B'59–80)
For later experiments, SP-B'59–80 was expressed using a pET31
construct (EMD Biosciences, Inc., Gibbstown, NJ) incorporating a
codon-optimized synthetic gene for SP-B59–80 (DNA2.0, Menlo Park,
CA) in BL21(DE3) cells with subsequent puriﬁcation and cleavage using
established protocols [30]. The expressed sequence of SP-B'59–80 was
modiﬁed to incorporate isoleucines in lieu ofmethionines (DTLLGRILP-
QLVCRLVLRCSID) for compatibility with a cyanogen bromide cleavage
reaction. Following HPLC puriﬁcation of the ﬁnal product, fractions
corresponding to SP-B'59–80 were collected and their purity was
veriﬁed by mass spectrometry with a mass to charge ratio (m/z) of
2497. Dried peptide was weighed and dissolved in methanol to a stock
concentration of approximately 1 mM, and aliquots were analyzed by
amino acid analysis for amore accurate determination of concentration
(Molecular Structure Facility, UC Davis). This peptide was used to
obtain results shown in Figs. 1, 5, 6, and 11 as well as the POPG-d31
results in Figs. 9 and 10. Its effects on lipid dynamics were ascertained
to be identical to those of the native sequence.
2.3. Preparation of peptide:lipid samples
POPC, DPPC, POPG, POPC-d31, DPPC-d62 and POPG-d31 were
purchased as chloroform solutions (Avanti Polar Lipids, Alabaster, AL)
Fig. 2. DSC scans for 4:1 DPPC-d62:POPG LUVs with SP-B59–80 at the indicated P:L molar
ratios.
2546 V.C. Antharam et al. / Biochimica et Biophysica Acta 1778 (2008) 2544–2554and concentrations were veriﬁed by phosphate analysis [31] (Bioassay
Systems, Hayward, CA). The lipids were mixed at a molar ratio of 4:1
DPPC:POPG and 3:1 POPC:POPG in chloroform and aliquoted. For
samples containing peptide, a methanol solution of SP-B59–80 was
added to lipid solutions with ﬁnal peptide: lipid (P:L) molar ratios
ranging from b1:1000 to N1:50. The samples were dried under a
stream of nitrogenwith the sample temperature maintained at 42–50°
in a water bath; the resulting ﬁlms were suspended in cyclohexane,
ﬂash-frozen, and lyophilized overnight to remove residual solvent.
2.4. CD experiments
3 mg of peptide-lipid powder was solubilized in 1 mL of 10 mM
HEPES buffer at pH 7.4, with 140 mM NaCl, to achieve a concentration
of 40 μM SP-B59–80 with 4 mM lipids. Samples were placed in a 50 °C
water bath to facilitate solubilization accompanied by 3–5 freeze-
thaw cycles with vortexing to achieve equilibration. Peptide-lipid
MLVs were extruded through 100 nm ﬁlters (Avanti Polar Lipids,
Alabaster, AL) 15–25 times above the Tm of the lipids to form LUVs just
prior to CD analysis. CD experiments were performed on an Aviv
Model 215 (Lakewood, NJ) at 45 °C using a 200–260 nm wavelength
range, a 1 nm step size and averaging of 40–50 scans. Background
contributions from the buffer and LUVs were removed by subtracting
appropriate controls.
2.5. DSC analysis
For each DSC sample, 2.2 mg of peptide-lipid powder was
solubilized in 1 mL 5 mM HEPES buffer at pH 7.4, with 140 mM NaCl
and 1 mM EDTA to achieve a 3 mM lipid concentration. Samples were
placed in a 50 °Cwater bath to facilitate solubilization accompanied by
3–5 freeze-thaw cycles with vortexing to achieve equilibration.
Peptide-lipid MLVs were extruded through 100 nm ﬁlters (Avanti
Polar Lipids, Alabaster, AL) 15–25 times at 45 °C to form LUVs and
degassed just prior to DSC. DSC experiments (Microcal Inc, LLC
Northampton) were conducted over a range of 10–70 °C at a scan rate
of 1 °C/min and run in triplicate.
2.6. Solid-state NMR analysis
For each solid-state NMR sample, 30 mg of peptide-lipid powder
was placed in a 5 mm diameter NMR tube and 200 μL of buffer
containing 5mMHEPES at pH 7.4, 140 mMNaCl, and 1mM EDTA in 2H
depleted water (Cambridge Isotopes, Andover MA) was added.
Samples were made using 4:1 DPPC-d62:POPG, 4:1 DPPC:POPG-d31,
3:1 POPC-d31:POPG, and 3:1 POPC:POPG-d31 lipid preparations. NMR
samples were then subjected to 3–5 freeze-thaw cycles with gentle
vortexing to form MLVs. 31P and 2H NMR data were collected on 500
and 600 MHz Bruker Avance systems (Billerica, MA) using standard
5mMBBOprobes. For 31PNMRexperiments, 25 kHzprotondecoupling
was employed during acquisition to remove dipolar couplings. Spectra
were acquired at 34, 39, and 44 °C to verify sample equilibration with
1024–2048 scans and a 5 s recycle delay between scans tominimize RF
sample heating. For the 2H NMR experiments, data were collected
using a quad echo sequence (90 °-τ-90 °-τ-acq with τ=30 μs) with a B1
ﬁeld of 40 kHz. Spectrawere acquired at 34, 39, and 44 °Cwith 1024 or
2048 scans and a 0.5 s recycle delay between scans. To monitor the
phase transitions of the lipids, for some samples spectra were also
collected over a range of 30–44 °C in 2° increments.
DePaking of NMR data was accomplished with previously
published algorithms which simultaneously dePake and determine
macroscopic ordering in partially aligned lipid spectra using Tikhonov
regularization [32]. 31P NMR spectra were referenced to phosphate
buffer prior to dePaking and dePaked spectra were quantitated by
ﬁtting the two peaks with Lorentzian line shapes. Assignments of 2H
resonances were made based on published values for DPPC [33,34].3. Results
3.1. Secondary structure
The CD spectra at 45 °C of SP-B'59–80 incorporated into lipid vesicles
are shown in Fig. 1. The CD spectra are characterized by double
minima at 206–208 and 222 nm, as is typically seen for peptide
helices. Interestingly, the spectra have a minimum ellipticity at 206–
208 signiﬁcantly lower than the minimum at 222 nm. Similar spectra
have been observed for KL4 in DPPC:POPG LUVs [24] and peptides
which are constrained to form π-helices in buffer [35]. Interpretation
of the CD spectra in terms of helix content is complicated by the fact
that SP-B59–80 does not form a typical amphipathic α-helix when
projected on a helical wheel. Fitting of the CD data with standard
deconvolution software [36] led to secondary structure estimates of
75–82% α-helix, 17–23% random coil, and negligible β-sheet for SP-
B59–80 interacting with POPC:POPG LUVs. Secondary structure
estimates of 98–100% α-helix with negligible random coil and β-
sheet populations were seen for SP-B59–80 interacting with DPPC:
POPG LUVs. However, the quality of the ﬁts was poor due to the non-
standard shape of the CD spectra and poor quality of the data below
200 nm due to light scattering from the lipids.
3.2. DSC indicates SP-B59–80 has little effect on DPPC:POPG lipid
miscibility
Fig. 2 shows DSC thermograms for 4:1 DPPC-d62:POPG LUVs
containing varying levels of SP-B59–80. The phase transition is not
dramatically inﬂuenced by the presence of SP-B59–80, although it
moves to slightly higher temperatures with increasing peptide
concentration. In contrast, KL4 has been shown by DSC and
ﬂuorescence microscopy to promote lipid phase separation and
domain formation [24,37,38]; no effects on the lipid miscibility are
seen at any molar percentages of SP-B59–80 studied here. The peak-
width at half height, or ΔT1/2, does not change signiﬁcantly upon
addition of SP-B59–80 indicating that the cooperativity of the phase
transition is not markedly inﬂuenced by the addition of SP-B59–80. The
relative differences between KL4 and SP-B59–80 are not completely
unexpected as KL4 contains solely hydrophilic residues that are
cationic while SP-B59–80 contains a mixture of cationic and anionic
residues. Thus, partitioning of KL4 with POPG may be more
energetically favorable, enhancing phase separation in DPPC/POPG
mixtures below the phase transition temperature of DPPC.
3.3. The interaction of SP-B59–80 with lipid headgroups
31P solid-state NMR for 4:1 DPPC:POPG and 3:1 POPC:POPG MLVs
with varying levels of SP-B59–80 were collected to assess the effect of this
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headgroups. Shown in Fig. 3 are 31P spectra for the DPPC-d62:POPG
samples at 44 °C. Also shown are the dePaked spectra allowing a clear
determination of the individual, time-averaged chemical shift aniso-
tropies (CSAs) of the PC and PG headgroups. Only lineshapes consistent
with lamellar phases are observed and the resonance for the POPG lipids
moves with addition of peptide; this is more evident after dePaking the
spectra. As seen in other studies [24,39,40], spontaneous macroscopic
lipid alignment occurs in the magnetic ﬁeld. Due to this phenomenon,
normally spherical MLVs undergo a deformation to more ellipsoidal
geometries, distorting the powder spectra. The extent of magnetic ﬁeld
alignment was accounted for in the dePaking algorithm [32]. The
difference in PG and PC CSAs is due to the difference in their preferred
headgroup orientations relative to the membrane normal [41]. With
increasing levels of SP-B59–80, the PC CSA is invariant, but the PG CSA
lessens with increasing peptide levels. The CSA for POPG alone is
signiﬁcantly smaller than observed for POPG in 4:1 DPPC:POPG or 3:1
POPC:POPGmixtures prior to the addition of SP-B59–80 [24]. However, for
the binary 4:1 DPPC:POPG mixture containing higher concentrations of
SP-B59–80, the 31P CSAs are more comparable to those of the neat lipids.
Thus, SP-B59–80 is clearlyaffecting the interactions of thePCandPG lipids.
Shown in Fig. 4 are 31P spectra for the POPC-d31:POPG samples at
44 °C and their dePaked counterparts. For 3:1 POPC:POPG MLVs,
addition SP-B59–80 leads to a considerably smaller decrease in the PG
CSA; in contrast, KL4 which has similar effects on the PG CSA in both
DPPC:POPG and POPC:POPG mixtures [24]. Based on these results,
when POPG is interacting with PC headgroups, electrostatic interac-Fig. 3. Phosphorous NMR spectra of 4:1 DPPC-d62:POPG MLVs with SP-B59–80 at the
indicated P:L molar ratios. (Top) Static NMR spectra and (Bottom) DePaked spectra.
Spectra were collected at 44 °C.
Fig. 4. Phosphorous NMR spectra of 3:1 POPC-d31:POPG MLVs with SP-B59–80 at the
indicated P:L molar ratios. (Top) Static NMR spectra and (Bottom) DePaked spectra.
Spectra were collected at 44 °C.tions cause the PG headgroups to reorient leading to a subsequent
increase in their averaged CSA values. Addition of surfactant peptide
disrupts this interaction, causing the PG CSAs to move toward values
seen for POPG alone; if the surfactant peptide is highly cationic,
electrostatic interactions lead to similar decreases in the POPG CSA
regardless of whether the PC lipid is fully saturated or monounsatu-
rated [24]. In the case of SP-B59–80, the negatively charged amino acids
at the termini result in less electrostatic interaction between the
peptide and the PG headgroup. However the partitioning of the
peptide into the DPPC:POPG lipids is sufﬁcient to signiﬁcantly alter the
orientation of the PG headgroup due to its overall effects on lipid
packing and dynamics; in POPC:POPG lipids it is not. The 31P NMR
spectra for 3:1 POPC-d31:POPG MLVs containing varying concentra-
tions of SP-B59–80 are typical for lamellar phases up to 1.7mol% peptide
(Fig. 4). However, the spectrum at 2.5 mol% peptide suggests the onset
of other bulk dynamics in the lipids, consistentwith exchange between
a lamellar phase andeither amicellar phase or a hexagonal phase.With
the onset of a phase transition at 2.5 mol% peptide, no clear distinction
between the PC and PG lipids can be made.
3.4. 2H NMR studies of DPPC:POPG lipid miscibility on addition of
SP-B59–80
To determine whether addition of SP-B59–80 causes phase separa-
tion of the DPPC and POPG lipids, 2H NMR spectra were collected over
the temperature range of the phase transitions for samples which
contained either deuterated DPPC or deuterated POPG (Fig. 5). A ﬁrst
moment analysis of the data was used to determine the phase
Fig. 5. Deuterium NMR spectra as a function of temperature for (a) 4:1 DPPC-d62:POPG MLVs, (b) 4:1 DPPC-d62:POPGMLVs with SP-B'59–80 at a P:L molar ratio of 1:100, (c) 4:1 DPPC:
POPG-d31 MLVs, and (d) 4:1 DPPC:POPG-d31 MLVs with SP-B'59–80 at a P:L molar ratio of 1:100.
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spectra, it is clear that in the 4:1 DPPC:POPG samples the lipids are
fully miscible with the DPPC and POPG melting at similar tempera-
tures. The phase transition seen for deuterated DPPC is at a slightly
lower temperature (midpoint of 30.6 °C) than for deuterated POPG
(32.7 °C). This is in part due to the fact that a larger percentage of the
fatty acyl chains are deuterated (80% vs. 10%) [42] but may also reﬂect
slight differences in POPG content between the two samples since
they were made from different lipid stock solutions. For the samples
that do not contain SP-B59–80, the spectra at intermediate melting
temperatures are a superposition of gel phase and liquid phase
spectra. Addition of SP-B59–80 affects the phase transition temperature
of both lipids with the phase transition temperature for DPPC-d62
increasing to 31.5 °C and the POPG-d31 phase transition temperature
decreasing to 30.3 °C. On addition of SP-B59–80, at lower temperatures
the POPG-d31 spectra have a larger percentage of the dynamic lipid
phase evident and in the DPPC-d62 spectra the dynamic phase is
absent, as can be seen by comparing spectra at 30 °C and 32 °C. The
peptide also leads to an increase in temperature at which the lipids are
completely melted (34 °C vs. 38 °C for deuterated DPPC; 36 °C vs. 38 °C
for deuterated POPG), consistent with the DSC data. Attempts toFig. 6. First moment, M1, as a function of temperature, for the 2H NMR spectra plotted in
Fig. 5; data for 4:1 DPPC-d62:POPGMLVs (open squares), 4:1 DPPC-d62:POPGMLVs with
SP-B'59–80 at a P:L molar ratio of 1:100 (closed squares), 4:1 DPPC:POPG-d31 MLVs (open
triangles), and 4:1 DPPC:POPG-d31 MLVs with SP-B'59–80 at a P:L molar ratio of 1:100
(closed triangles) show the variations in the melting temperatures of the lipids on
addition of peptide.determine the fractions of liquid phase and gel phase by spectral
subtractions with samples containing differing percentages of SP-B59–
80 were unsuccessful due to variations in the lipid alignment and acyl
chain order parameters. Thus, addition of SP-B59–80 leads to some
phase separation of the lipids at lower temperatures with a signiﬁcant
fraction of POPG remaining in the gel phase; at higher temperatures,
the lipids exhibit similar spectra consistent with the lipids becoming
fully miscible. These differences are too subtle to be observed via
differential scanning calorimetry. Above the phase transition tem-
perature of the domainwith the higher Tm, the peaks in the 2H spectra
coalesce to a single resonance for each position in the acyl chains
suggesting the absence of separate domains in the ﬂuid phase or
exchange between domains is fast on the NMR time scale.
3.5. Effects of SP-B59–80 on lipid acyl chains
2H NMR spectra of DPPC-d62:POPG and POPC-d31:POPG MLVs at
44 °C with varying levels of SP-B59–80 (Figs. 7 and 8) allow
determination of the effect of this membrane-active peptide on lipid
dynamics in the ﬂuid phase and insight into the depth of peptide
penetration. For 3:1 POPC-d31:POPG MLVs, decreases are seen in the
ordering of the POPC sn-1 acyl chains on addition of SP-B59–80. This
suggests the peptide binds to the interface, increasing the lateral
spacing between the lipids, allowing more motion in the acyl chains.
In contrast, addition of SP-B59–80 to 4:1 DPPC-d62:POPG MLVs
increases the ordering of the DPPC acyl chains, particularly toward
the middle of the bilayer. This suggests either 1) insertion of SP-B59–80
deeply into the DPPC:POPG bilayers, restricting the motional freedom
of the acyl chains, or 2) an electrostatic interaction of the peptide with
the lipid headgroups resulting in a change in the lipid packing and
headgroup conformation. Also shown in Figs. 7 and 8 are the dePaked
spectra which allow assignment of each C–D bond in the acyl chain
and determination of the time-averaged order parameters, bSCDN. For
samples in which the lipid bilayers show a tendency to align in the
magnetic ﬁeld, the dePaking must take into account the effects of lipid
alignment on the probability distribution function. Assuming the
magnetic ﬁeld leads to an ellipsoidal deformation of the MLVs, the
probability distribution becomes [32]:
p Eð Þ θð Þ~ sin θð Þ 1− 1−κEð Þ cos2θ
h i−2
ð1Þ
where κE refers to square of the ratio of the long to short axes of the
ellipsoids. Using Tikhonov regularization, κE and the dePaked spectra
were determined simultaneously. Lipid acyl chain order parameter
Fig. 7. Deuterium NMR spectra of 4:1 DPPC-d62:POPGMLVs with SP-B59–80 at the indicated P:L molar ratios. Spectra were taken at 44 °C. (Top) Static NMR spectra; (Bottom) dePaked
spectra.
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spectra, measuring the quadrupolar splitting (ΔvQ) for deuterium
atoms at various positions along the acyl chain, and determining their
order parameter using Eq. (2), where 34
e2qQ
h is the quadrupolar coupling
of the deuterium nucleus to the electric ﬁeld gradient. A static
quadrupolar coupling of 167 kHz [44] was assumed in calculating the
order parameters.
ΔυQ =
3
4
e2qQ
h
3 cos2 θ−1
 
SCD ð2Þ
Comparison of these order parameter proﬁles to those for the
individual lipids show that the DPPC order parameters for 4:1 DPPC:
POPG MLVs with P:L ratios N1:200 are higher than would be
expected for DPPC alone [24]. Within the resolution of the 2H NMR
experiment, no phase separation is seen. The proﬁles also yield a
more detailed picture of how SP-B59–80 affects the lipid dynamics
with carbon positions 9–16 the most affected in the PC lipid acyl
chains for both lipid systems. The effects of SP-B59–80 on the PG lipids
were similarly monitored by collecting 2H NMR spectra for 4:1 DPPC:
POPG-d31 and 3:1 POPC:POPG-d31 MLVs, dePaking the spectra, and
generating order parameter proﬁles. The order parameter proﬁles for
the sn-1 chain on POPG in these lipid mixtures are also given in Figs.
9 and 10. In these experiments an overall decrease in ordering of the
POPG acyl chains is seen on addition of SP-B59–80. Decreases in the
order parameters are seen at all the acyl positions in POPG in 3:1
POPC:POPG MLVs and are slightly larger than the changes for POPC.
The POPG acyl chain order parameters in 4:1 DPPC:POPG MLVs do
not appear to be as affected by SP-B59–80, however a comparison of
the results further down the acyl chain for POPG-d31 when mixed
with DPPC vs. POPC again demonstrates that the peptide interacts
with these lipid systems in a manner dependant on the degree of
saturation of the fatty acid chains.Since SP-B59–80 is most likely interacting with both lipid popula-
tions in the ﬂuid phase rather than segregating the lipids and
interacting with a single phase above the Lβ to Lα phase transition, the
changes in POPG-d31 and DPPC-d62 order parameter proﬁles on
addition of SP-B59–80 to DPPC:POPG MLVs may seem to be contra-
dictory. The observed changes in order parameters can be reconciled
when the data are viewed as the change in order parameter at each
position along the acyl chain on addition of peptide relative to the
order parameters of the lipids without the peptide. Shown in Fig. 11
are the changes in order parameters at particular methylene positions
in the sn-1 palmitoyl acyl chains for the individual lipids in 3:1 POPC:
POPG and 4:1 DPPC:POPGMLVs, respectively, on addition of peptide at
a P:L molar ratio on the order of 1:100. From these graphs, the
behavior of the PG lipids relative to the PC lipids is clearly offset, but
the trends with respect to acyl chain position are similar. The offset of
the proﬁles for the PG lipids is consistent with 31P NMR ﬁndings
described above showing that association of SP-B59–80 with the lipids
leads to a change in the orientation PG headgroup and an overall
decrease in the 31P CSA for the POPG lipids. Thus, the offset in the PG
proﬁles in Fig. 11 relative to the PC proﬁles does not reﬂect
signiﬁcantly less internal order in the PG lipid methylene chains per
se, but instead reﬂects a change in the average orientation of the PG
lipid director relative to the membrane normal. The degree of offset
for the POPG proﬁles in the DPPC:POPG and POPC:POPG mixtures
correlate with the degree to which the POPG 31P CSA is affected by
addition of peptide. Thus the addition of SP-B59–80 is most likely
equally affecting the internal dynamics of the methylene chains in
both lipids in a similar manner. From their proﬁles, the methlyenes in
the plateau region are less affected than those further down the acyl
chain in the POPC:POPG lipid system. This behavior is similar to
changes observed on addition of antimicrobial peptides, which
typically cause larger changes in order further down the methylene
chain [27,45,46], but is in contrast to the interaction of KL4 [24] or
Fig. 8. Deuterium NMR spectra of 3:1 POPC-d31:POPG MLVs with SP-B59–80 at the indicated P:L molar ratios. Spectra were taken at 44 °C. (Top) Static NMR spectra and (Bottom)
dePaked spectra.
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effect on the plateau region.
Of particular interest to the roles of SP-B59–80 and KL4 in lung
surfactant formulations are their similar effects on 4:1 DPPC:POPG
MLVs. Previously we have observed that KL4 increases order along the
DPPC acyl chains with its greatest effect at the center of the bilayers,
and this same trend is seenwith SP-B59–80. The proﬁle for POPG shows
little change in order toward the center of the bilayers and a decrease
in the plateau region. However, as discussed above, these differences
reﬂect a change in the average orientation of the POPG headgroup and
if this change in orientation is taken into account, the internal order at
individual methylene positions in the POPG acyl chain is likely
increasing over the entire length of the acyl chain. Increases in lipid
acyl chain ordering have been observed in response to polyelectrolyte
binding to lipid headgroups [49,50] as well as in response to the
addition of small molecules, such as cholesterol [51,52], or transmem-
brane peptide helices which partition into the acyl chain region of the
lipids [53,54]. In the case of polyelectrolyte binding, larger changes are
seen for the plateau region of the lipids reﬂecting a change in overall
orientation of the lipids due to changes in packing of the headgroups.
Smaller changes are also seen near the center of the bilayers and are
interpreted as resulting from closer packing of the lipids on binding
of the electrolyte. For transmembrane helices similar in length
to SP-B59–80, increases in order parameters which are similar in mag-
nitude are seen for both the methylene positions in the plateau region
and toward the center of the bilayers; these trends areobserved in both
POPC and DPPC bilayers. This is expected since insertion of a
transmembrane peptide of this length primarily affects the thicknessof the bilayer and would interact with both the lipid acyl chains and
headgroups across the entire span of the bilayers. In contrast, on
addition of cholesterol, larger changes in order parameters are
observed toward the center of the bilayer [51] since cholesterol
partitions to the bilayer interior and does not strongly interactwith the
lipid head groups. Interestingly, the effects of SP-B59–80 and KL4 on
order in DPPC:POPG bilayers are most similar to cholesterol, suggest-
ing the bulk of each peptide is partitioning deep within the lipid
bilayers. The higher degree of ordering toward the center of the bilayer
suggests the surfactant peptides arepenetrating deeply into the bilayer
and decreasing the mobility of the acyl chains. However, the smaller
changes seen in the plateau region (carbons 3–8) suggest the peptides
do not adopt a transmembrane orientation. The thermodynamic
penalty imposed by placing SP-B59–80 in a transmembrane orientation
would be prohibitive since it would place the hydrophilic amino acids
at positions 6, 10, 14, and 16 into the hydrophobic core [55]. Thus, the
changes in order parameters indicate SP-B59–80 lodges into the
hydrophobic region of the bilayer, while maintaining a perpendicular
orientation to the bilayer normal. This type of interactionwould lead to
a negative curvature strain within the lipid bilayers, a phenomenon
which has been hypothesized as being important to lung surfactant
function [56]. A recent solution NMR study of SP-B63–78 bound to SDS
micelles found the peptide forms an amphipathic helix at the water
interface with the hydrophilic residues solvent accessible [13],
consistent with our interpretation.
Looking at the same sn-1 C–D positions for POPC-d31 in 3:1 POPC:
POPG MLVs (Figs. 10 and 11), it can be seen that SP-B59–80 decreases
order by as much as 20%, with the largest decrease in ordering seen for
Fig. 9. Order parameter proﬁles for the sn-1 chains of DPPC-d62 (top) and POPG-d31
(bottom) in 4:1DPPC:POPGMLVs at 44 °Cwith SP-B59–80 at the indicated P:Lmolar ratios.
Fig. 10. Order parameter proﬁles for the sn-1 chains of POPC-d31 (top) and POPG-d31
(bottom) in 3:1 POPC:POPGMLVs at 44 °Cwith SP-B59–80 at the indicated P:Lmolar ratios.
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interface of 3:1 POPC:POPG MLVs and increasing the area per lipid
molecule leading to more motion in the acyl chains. A striking
decrease in the plateau region is seen at 2.5 mol% peptide along with
the appearance of an isotropic peak in the 2H spectrum (Fig. 8),
consistent with the 31P NMR data suggesting that this concentration of
peptide leads to destabilization of the lamellar phase and exchange of
the lipids between a lamellar and nonlamellar phase.
From these results we conclude that the penetration and inter-
action of SP-B59–80 with the lipids in lung surfactant is dependent on
the degree of saturation in the lipids. Intriguingly, the peptide
penetrates deeply into mixtures containing a high level of saturated
lipids even though the order of the fatty acyl chains in these lipids is
higher than those in monounsaturated lipids. When interacting with
monounsaturated lipids, SP-B59–80 binds at the interface and has
effects similar to other amphipathic peptides, including antimicrobial
peptides, which increase curvature strain in the lipids and can
cause micelle formation at higher concentrations. The interaction of
SP-B59–80 with these binary lipid systems is on the whole very similar
to behavior previously seen for KL4, suggesting the two peptides have
very similar mechanisms of binding and similar effects on the
dynamics of the lipids.
4. Discussion
The effects of the C-terminal region of SP-B, speciﬁcally residues
59–80, on lipid dynamics and acyl chain ordering were explored in
two binary lipid systems that differ in their degree of monounsatura-
tion. SP-B59–80 has been used as a template for the design of simple
molecules for the treatment of respiratory distress syndrome (RDS),the most notable of these being the 21 amino acid peptide KL4 which
has shown exceptional efﬁcacy in lung surfactant formulations,
particularly when compared to more conventional therapies that
rely upon exogenous sources of SP-B [57]. The SP-B59–80 peptide is
presumed to be helical when interacting with lipids based on the
distribution of charged and uncharged residues in its primary amino
acid sequence and this is borne out by our CD data. To date, few studies
examining the structure of SP-B59–80 and its interactions with lipids
have been carried out despite its demonstrated surface activity and
role in the rational design of KL4. Additionally, subsequent studies of
KL4 have suggested its properties might be more similar to SP-C,
which is a small, highly hydrophobic transmembrane protein in
contrast to SP-B, which is found at membrane interfaces. Previously
we have examined the structure of KL4 [25] and found it to be
consistent with the peptide partitioning in bilayers with the helix axis
perpendicular to themembrane normal, but its depth of penetration is
dependent on the degree of saturation in the lipids [24]. Whether SP-
B59–80 binds similarly to lipid interfaces and affects the properties of
the lipids in the same manner is the subject of this study.
While the sequence of KL4 is based on SP-B59–80, there are some
notable differences in their primary amino acid sequences. First, KL4
contains only two types of amino acids, the hydrophobic leucine and
cationic lysine; in SP-B59–80 the distribution of hydrophobic and
hydrophilic residues is similar, but the hydrophilic amino acids are a
mixture of anionic (D59 and D80), polar (Q68) and cationic (R64, R72, and
R76) residues at physiologic pH. The spacing of lysines in KL4 is based
on the ﬁve charged amino acids in SP-B59–80, but the preponderance of
long, cationic sidechains would allow more favorable electrostatic
interactions with the anionic POPG lipids and phospholipid interfaces
in general. If both peptides form amphipathic helices at lipid
Fig. 11. Changes in d31-palmitoyl acid chain order parameters in 4:1 DPPC:POPG MLVs
(top) and 3:1 POPC:POPGMLVs (bottom) on addition of SP-B'59–80 at a P:L molar ratio of
1:100.
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spacing of the polar residues in SP-B59–80 is primarily every four
residues rather than every ﬁve residues, as in KL4. We have found that
KL4 has the ability to deeply embed in DPPC-rich bilayers, which we
have attributed to the lysine sidechains being able to snorkel up to the
phosphates at the lipid interface [24]. While arginine residues would
also allow this behavior, the aspartic acid residue sidechains at the
ends of SP-B59–80 would be too short and the electrostatic interactions
with the phosphate moieties would be unfavorable. Finally, the
occurrence of a proline residue at position 67 in SP-B59–80 could affect
the helical nature of the peptide. Nonetheless, both peptides have
been demonstrated to be surface active and effective in lowering
surface tension at air/water interfaces.
Based on the DSC data, SP-B59–80 does not have the same effect
on the macroscopic phase properties of DPPC:POPG mixtures as KL4.
DSC experiments performed by Saenz, et al. [37] and our group [24] asFig. 12.Models of SP-B59–80 interactions with the two lipid environments studied assuming a
into 4:1 DPPC:POPG lipid bilayers. (Right) In contrast, in 3:1 POPC:POPG MLVs lipids, a mo
transmembrane orientation of the peptide is unlikely as it would place four polar residueswell as epiﬂuorescence studies [38] indicate that KL4 mediates
phase separation inDPPC:POPGenvironments. In contrast, DSC indicates
SP-B59–80 has little effect on the thermodynamic properties of DPPC:
POPG LUVs other than small effects on the cooperativity of the Lβ to Lα
phase transition.However, the 2HNMRdata show there is a small degree
of phase separation in the gel phase on addition of SP-B59–80.
In contrast to the calorimetry data, which reports on bulk
thermodynamic properties of the lipids, 31P and 2H NMR data
monitoring lipid dynamics above the phase transition temperature
show the two peptides interact similarly with lipid vesicles and have
similar effects on lipid dynamics in 4:1 DPPC-d62:POPG lipid
environments. The 31P NMR data indicate that neither peptide affects
the DPPC CSA, while both peptides affect the POPG CSA. While an
interaction of SP-B59–80 with the anionic PG headgroups is one
plausible explanation of this data, it should be noted that SP-B59–80
does not possess the distinct cationic charge periodicity found in
KL4; the sole use of lysines for charged residues in KL4 could allow
for a more enhanced electrostatic interaction with PG compared to
SP-B59–80. This fact is borne out by quantitative comparison of the
data for the two peptides. The changes in the POPG CSA, which report
on changes in the average orientation of the POPG headgroups, with
increasing concentrations of SP-B59–80 are less than half those seen
for KL4. Changes caused by SP-B59–80 can be attributed to the peptide
generally affecting lipid-lipid interactions rather than a direct
electrostatic interaction with the POPG headgroups. However,
addition of either peptide leads to increases in the time-averaged
deuterium order parameters for the DPPC lipids, particularly at
carbons 9–15. These increases suggest equally deep penetration of
the peptides into the DPPC:POPG bilayers and are similar in scale for
both peptides. For both peptides a transmembrane orientation is
unlikely as this would place 3–4 polar amino acids into the bilayer
interior. In this regard, our observations support KL4 and SP-B59–80
partitioning similarly into DPPC:POPG lipid bilayers.
In 3:1 POPC-d31:POPG lipids, the changes in the 31P CSAs for the
lamellar vesicles on addition of SP-B59–80 are smaller than those seen in
4:1 DPPC:POPG samples or on addition of KL4 to POPC:POPG mixtures.
However, at 2.5 mol% SP-B59–80, a striking difference is seen in the 31P
powder patterns suggesting the onset of exchange between the lipid
lamellar phase and a more dynamic lipid phase. The 2H NMR order
parameters decrease with increasing peptide concentrations. These
increases in fattyacidmobilityare similar to the trends found forKL4, but
the changeswith SP-B59–80 are considerablygreater inmagnitude. These
ﬁndings indicate that the SP-B59–80 remains in the interfacial region of
the lipid bilayers at lower concentrations. At 2.5 mol% SP-B59–80, a
large coalesced peak in the center of the 2H spectrum appears
indicating the formation of a second, non-bilayer lipid phase is
occurring. The 31P and 2H NMR data are consistent with the formation
of small vesicles with motions that are fast on the NMR timescale, and
may also implicate SP-B59–80 in lipid shuttling, lysis or degradation.
Lipid lysis and degradation has been suggested as one of the many
functions of SP-B that could be necessary for effective surfactant
recycling and remediation [58,59]. An antimicrobial function has
also been attributed to SP-B, and the lipid dynamics seen at 2.5 mol%
SP-B59–80 are similar to behavior seen with higher concentrations ofhelical peptide conformation. (Left) Based on 2H NMR data, SP-B59–80 deeply penetrates
re peripheral interaction of SP-B59–80 with the lipid headgroup region is proposed. A
in the hydrophobic interior.
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and synthetic derivatives [27,45,46,60]. This function is of particular
interest as well to the saposin protein family, of which SP-B is the most
hydrophobic member; this family includes several proteins which bind
and trafﬁc lipids for enzymatic modiﬁcation or degradation [5].
However, further studies are needed to differentiate between either a
role for SP-B59–80 in lipid degradation or in forming nonlamellar phases.
Interestingly, we only saw this effect in 3:1 POPC:POPG, and not in
DPPC:POPG at 2.5mol% SP-B59–80. This suggests the activity of SP-B59–80
is dependent on the saturation level of the acyl chains in a
concentration dependent manner and provides a means of discrimina-
tion between lipids in the dynamic lung environment.
Based on the CD, 31P NMR and 2H NMR data, a model of how SP-
B59–80 interacts with these lipid systems can be put forth (Fig. 12). It
should be noted that in this model we assume that SP-B59–80 is helical
in a lipid environment, based on our CD data, and we propose that the
peptide assumes an orientation in which the helix axis is perpendi-
cular to the membrane normal due to the occurrence of charged
residues throughout the primary sequence. Such an assumption is
valid given the ﬁndings in the literature pertaining to the helical
nature of SP-B and in particular the C-terminal region [8,13,61,62].
However, from examination of the primary amino acid sequence and
our 2H NMR derived order parameters it is conceivable that the type
of helical structure SP-B59–80 adopts may not be a canonical α-helix
and the pitch of the helix may change as the peptide more deeply
penetrates into the saturated lipid environments. For KL4, this type of
structural transition has been observed by solid-state MAS NMR
experiments (Mills, F.D. and Long ,J.R., unpublished data). To answer
the question of the type of helix SP-B59–80 forms in a lipid
environment, similar MAS NMR experiments on 13C labeled peptide
in complex with lipids need to be performed.
Since an increase in DPPC acyl chain ordering is seen on addition of
SP-B59–80 to 4:1 DPPC:POPG lipid vesicles, we conclude the peptide
penetrates deeply into the hydrophobic region of the lipids and
restricts acyl chain motion. In 3:1 POPC:POPG lipid vesicles, the
disordering of the acyl chains indicate that the peptide is at the lipid/
buffer interface in this lipid system. This is consistent with the CD data
which shows solely a helical conformation for SP-B59–80 when it is
interactingwith 4:1 DPPC:POPG vesicles, suggesting complete binding
of the peptide, and a mixture of helix and random coil when it is
interacting with 3:1 POPC:POPG vesicles, suggesting the peptide
might partition between the lipid interface and aqueous phases. The
results for addition of SP-B59–80 to DPPC:POPG suggest the peptide
may deeply penetrate into the bilayer with the charged sidechains
“snorkeling” to the interface as we have postulated to occur for KL4.
The snorkeling hypothesis is particularly relevant to KL4 since all of
the charged residues are lysines. However, while SP-B59–80 also has
periodically spaced charged residues, the aspartic acid sidechains are
not as long and would not interact as favorably with the phosphate
moieties. We are currently pursuing EPR and NMR studies which will
allow reﬁnement of our model. This will yield more accurate
information in terms of orientation, depth penetration and structure
of the peptide at particular amino acids. However, from the current
study we can conclude that SP-B59–80 interactions with lung
surfactant lipids and subsequent changes in lipid dynamics are
dependent on the level of fatty acid saturation. While SP-B59–80 and
KL4 behave similarly in this regard, key differences are also evident. In
particular, SP-B59–80 is able to alter bilayer structure in POPC:POPG
vesicles at a concentration as low as 2.5 mol% while KL4 is able to
facilitate phase separation in DPPC:POPG vesicles. The phase separa-
tion characteristics of KL4 may be of key relevance to the peptide's
success in the clinic and can most likely be attributed to the use of
solely positively charged residues rather than a mixture of cationic
and anionic residues. The properties of SP-B59–80 in POPC:POPG
vesicles may be due to the fact that polar and charged residues are
spaced every four residues instead of every ﬁve residues leading tosubtle changes in the structure and interaction of the peptide with the
lipid lamellae relative to KL4; alternatively electrostatic interactions
may lead to the peptide being even more peripherally located in the
lipid/water interface in comparison to KL4.
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